Award
Delivery Order #SPE2D326F7382
Short-Term Delivery Order for Mucinex Tablets to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$49.30
Ceiling
$49.30
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2D326F7382
NAICS
325411
This award is a short-term delivery order contract granted to DMS Pharmaceutical Group Inc, a pharmaceutical manufacturer and distributor known for supplying injectable and oral medications. Under this order, DMS Pharmaceutical Group is tasked with the delivery of Mucinex ER 600 mg tablets, a medicine used to relieve cough and chest congestion. The contract signifies the continuation of a broader multi-year Indefinite Delivery Indefinite Quantity (IDIQ) agreement with the U.S. government aimed at ensuring a reliable supply of essential pharmaceutical products. The scope includes the timely procurement and delivery of the specified medication within a concise timeframe, supporting ongoing medical readiness and public health needs. This delivery order is issued under the umbrella of the existing IDIQ contract, which facilitates flexible and responsive pharmaceutical procurement without fixed quantities. The contract was likely awarded through competitive mechanisms consistent with the parent IDIQ. Key milestones include a contract performance period spanning a few days in early March 2026. The short duration and specific product focus highlight this award's role as part of a responsive supply chain fulfilling immediate government pharmaceutical requirements.
Description
4571056569!MUCINEX ER 600 MG TABLET 20S